News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
717,772 Results
Type
Article (40677)
Company Profile (270)
Press Release (676819)
Multimedia
Podcasts (76)
Webinars (17)
Section
Business (204567)
Career Advice (2018)
Deals (35508)
Drug Delivery (105)
Drug Development (81312)
Employer Resources (173)
FDA (16372)
Job Trends (14929)
News (346156)
Policy (32700)
Tag
Academia (2558)
Accelerated approval (23)
Adcomms (24)
Allergies (123)
Alliances (49575)
ALS (157)
Alzheimer's disease (1622)
Antibody-drug conjugate (ADC) (265)
Approvals (16558)
Artificial intelligence (454)
Autoimmune disease (115)
Automation (33)
Bankruptcy (361)
Best Places to Work (11638)
BIOSECURE Act (20)
Biosimilars (173)
Biotechnology (176)
Bladder cancer (147)
Brain cancer (51)
Breast cancer (587)
Cancer (4391)
Cardiovascular disease (358)
Career advice (1700)
Career pathing (34)
CAR-T (261)
CDC (44)
Celiac Disease (1)
Cell therapy (682)
Cervical cancer (34)
Clinical research (69002)
Collaboration (1465)
Company closure (4)
Compensation (1039)
Complete response letters (46)
COVID-19 (2694)
CRISPR (81)
C-suite (685)
Cystic fibrosis (136)
Data (5682)
Decentralized trials (2)
Denatured (25)
Depression (112)
Diabetes (455)
Diagnostics (6601)
Digital health (38)
Diversity (11)
Diversity, equity & inclusion (45)
Drug discovery (212)
Drug pricing (166)
Drug shortages (28)
Duchenne muscular dystrophy (211)
Earnings (89729)
Editorial (50)
Employer branding (21)
Employer resources (151)
Events (116574)
Executive appointments (937)
FDA (19111)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (20)
Funding (1320)
Gene editing (180)
Generative AI (38)
Gene therapy (538)
GLP-1 (912)
Government (4624)
Grass and pollen (6)
Guidances (376)
Healthcare (18858)
HIV (48)
Huntington's disease (39)
IgA nephropathy (75)
Immunology and inflammation (229)
Immuno-oncology (36)
Indications (76)
Infectious disease (2934)
Inflammatory bowel disease (178)
Inflation Reduction Act (13)
Influenza (100)
Intellectual property (209)
Interviews (315)
IPO (16622)
IRA (48)
Job creations (3640)
Job search strategy (1427)
Kidney cancer (15)
Labor market (79)
Layoffs (541)
Leadership (28)
Legal (7941)
Liver cancer (88)
Longevity (12)
Lung cancer (606)
Lymphoma (349)
Machine learning (37)
Management (59)
Manufacturing (669)
MASH (152)
Medical device (13686)
Medtech (13723)
Mergers & acquisitions (19847)
Metabolic disorders (1137)
Multiple sclerosis (143)
NASH (16)
Neurodegenerative disease (276)
Neuropsychiatric disorders (69)
Neuroscience (2700)
NextGen: Class of 2025 (6518)
Non-profit (4501)
Now hiring (60)
Obesity (527)
Opinion (247)
Ovarian cancer (149)
Pain (173)
Pancreatic cancer (190)
Parkinson's disease (251)
Partnered (31)
Patents (444)
Patient recruitment (391)
Peanut (54)
People (58521)
Pharmaceutical (63)
Pharmacy benefit managers (26)
Phase I (21502)
Phase II (30373)
Phase III (22645)
Pipeline (3800)
Policy (260)
Postmarket research (2564)
Preclinical (9162)
Press Release (64)
Prostate cancer (214)
Psychedelics (43)
Radiopharmaceuticals (264)
Rare diseases (708)
Real estate (5948)
Recruiting (69)
Regulatory (23930)
Reports (51)
Research institute (2372)
Resumes & cover letters (351)
Rett syndrome (23)
RNA editing (12)
RSV (73)
Schizophrenia (134)
Series A (216)
Series B (165)
Service/supplier (11)
Sickle cell disease (91)
Special edition (20)
Spinal muscular atrophy (153)
Sponsored (40)
Startups (3607)
State (2)
Stomach cancer (16)
Supply chain (97)
Tariffs (80)
The Weekly (49)
Vaccines (944)
Venture capital (74)
Weight loss (340)
Women's health (74)
Worklife (17)
Date
Today (122)
Last 7 days (530)
Last 30 days (2388)
Last 365 days (30265)
2025 (29664)
2024 (35220)
2023 (40076)
2022 (51175)
2021 (55711)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32108)
2016 (31481)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (734)
Alabama (77)
Alaska (7)
Arizona (288)
Arkansas (13)
Asia (38937)
Australia (6363)
California (10387)
Canada (3086)
China (971)
Colorado (433)
Connecticut (445)
Delaware (307)
Europe (83929)
Florida (1538)
Georgia (330)
Hawaii (2)
Idaho (61)
Illinois (780)
India (54)
Indiana (491)
Iowa (20)
Japan (362)
Kansas (122)
Kentucky (36)
Louisiana (24)
Maine (70)
Maryland (1305)
Massachusetts (7485)
Michigan (301)
Minnesota (585)
Mississippi (5)
Missouri (120)
Montana (30)
Nebraska (26)
Nevada (112)
New Hampshire (73)
New Jersey (2802)
New Mexico (28)
New York (2766)
North Carolina (1355)
North Dakota (8)
Northern California (4986)
Ohio (305)
Oklahoma (20)
Oregon (38)
Pennsylvania (2129)
Puerto Rico (19)
Rhode Island (45)
South America (1100)
South Carolina (58)
South Dakota (1)
Southern California (4020)
Tennessee (163)
Texas (1600)
United States (37103)
Utah (306)
Vermont (1)
Virginia (238)
Washington D.C. (78)
Washington State (851)
West Virginia (4)
Wisconsin (90)
Wyoming (2)
717,772 Results for "maxcyte inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MaxCyte Announces Planned CFO Transition in 2026
November 13, 2025
·
2 min read
Press Releases
MaxCyte Reports Third Quarter 2025 Financial Results and Reiterates Full Year 2025 Revenue Guidance
November 13, 2025
·
15 min read
Press Releases
MaxCyte to Report Third Quarter 2025 Financial Results on November 5, 2025
October 9, 2025
·
1 min read
Press Releases
MaxCyte Reports Preliminary Third Quarter 2025 Financial Results and Reiterates Full Year 2025 Revenue Guidance
November 6, 2025
·
9 min read
Press Releases
MaxCyte Announces Operational Restructuring to Reduce Costs and Accelerate Path to Profitability
September 23, 2025
·
4 min read
Press Releases
MaxCyte Announces Strategic Platform License Agreement with Moonlight Bio to Advance T Cell Therapies for Solid Tumors
October 7, 2025
·
4 min read
Press Releases
Cellares Appoints Former MaxCyte Commercial Chief Ali Soleymannezhad as Chief Commercial Officer to Lead Global IDMO Expansion, Catalyze Next Wave of Partnerships, Prepare for IPO
December 2, 2025
·
5 min read
Press Releases
PHC Announces Exclusive Distribution of MaxCyte® ExPERT™ Platform in Japan
July 1, 2025
·
5 min read
Press Releases
MaxCyte to Report Second Quarter 2025 Financial Results on August 6, 2025
July 10, 2025
·
1 min read
Press Releases
MaxCyte Reports Second Quarter 2025 Financial Results and Updates Full Year 2025 Guidance
August 7, 2025
·
15 min read
1 of 71,778
Next
